PDCD1LG2 and neoplasm: While we have not studied the expression levels of PDL-1 or PDL-2 in this model, there is clinical evidence to support increased PDL-1 expression in a significant portion of BCC tumor cells and tumor-infiltrating immune cells [44,45,46].